New Silkroutes Group, Acclivis to deploy workflow for genome-focused AI platform

It will be used to provide unique healthcare solutions across the joint venture's active markets.

Investment holding company New Silkroutes Group (NSG) and tech services provider Acclivis have signed a non-binding memorandum of understanding (MOU) to design and develop a comprehensive workflow for a cloud-based artificial intelligence (AI) platform that can be used to provide genomic-driven healthcare.

NSG plans to develop an AI platform that will be able to pull genomics data from cloud data storage for use in different data analysis modules. The system will then produce customised clinical reports for medical practitioners and clinicians.

As the system has machine learning capability, it should also become more intelligent with time and increased utilisation.

“We have been working hard to enhance our AI capabilities to transform ourselves into a tech-enabled healthcare group that will provide patients with the best diagnosis and treatment,” NSG CEO VicPearly Wong said.

Under the MOU, Acclivis will also help to build a private AI cloud facility and develop a secure network connection within NSG’s operational facilities.

“Acclivis has a track record of building and managing private cloud facilities and developing AI technology platforms that define, structure and automate workflows for the public, commercial and healthcare sectors. We are delighted to partner with NSG to positively shape the future of genomics healthcare,” Acclivis CEO Marcus Cheng said.

NSG, which operates a network of medical and dental clinics in Singapore, will own the intellectual property rights for the workflow and UI/UX.